Chlamydia pneumoniae pathogenesis

Journal of Medical Microbiology

Volumn 51, Issue 8, 2002, Pages 623-625

  Campbell, Lee Ann ^a   Kuo, Cho Chou ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; DISEASE ASSOCIATION; EDITORIAL; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; ADOLESCENT; ADULT; ANIMAL; ARTERIOSCLEROSIS; CHILD; DISEASE MODEL; MICROBIOLOGY; MOUSE; PATHOGENICITY; PATHOLOGY;

ADOLESCENT; ADULT; ANIMALS; ARTERIOSCLEROSIS; CHILD; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DISEASE MODELS, ANIMAL; HUMANS; MICE; RABBITS;

EID: 0035984544     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-51-8-623     Document Type: Editorial

References (27)

1. Chlamydia pneumoniae (TWAR)
2. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis
3. Chlamydia pneumoniae and cardiovascular disease
4. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
5. Detection of Chlamydia pneumoniae in arterial tissues
6. Chlamydia pneumoniae in atherosclerotic tissue
7. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques
8. Atherosclerosis - An inflammatory disease
9. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice
10. ApoE deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
11. Mouse models of C. pneumoniae infection and atherosclerosis
12. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors
13. Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease
14. Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice
15. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae
16. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
17. Rabbit model for Chlamydia pneumoniae infection
18. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits
19. Chlamydia, inflammation, and atherogenesis
20. Chlamydia pneumoniae and atherosclerosis: Does the evidence support a causal or contributory role?
21. Chlamydial virulence determinants in atherogenesis: The role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions
22. Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae induced secretion of pro-inflammatory cytokines
23. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages
24. Chlamydia pneumoniae facilitates monocytes adhesion to endothelial and smooth muscle cells
25. Monocyte-endothelial cell co-culture enhances infection of endothelial cells with Chlamydia pneumoniae
26. Human monocyte-derived insulin-like growth factor-2 enhances the infection of human arterial endothelial cells by Chlamydia pneumoniae
27. Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s)